These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21654589)

  • 1. Occult hepatitis B in Cuban HIV patients.
    Marité B; Montalvo MC; Rodríguez Lde L; Sariego S; Verdasquera D; Vincent M; Gutiérrez A; Sánchez M
    MEDICC Rev; 2011 Apr; 13(2):32-7. PubMed ID: 21654589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Investigation of occult hepatitis B in HIV infected patients].
    Altınbaş A; Ergünay K; Calık Başaran N; Alp A; Turgut D; Hasçelik G; Uzun Ö; Unal S
    Mikrobiyol Bul; 2011 Apr; 45(2):353-8. PubMed ID: 21644079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overt and occult hepatitis B virus infection in adult Sudanese HIV patients.
    Mudawi H; Hussein W; Mukhtar M; Yousif M; Nemeri O; Glebe D; Kramvis A
    Int J Infect Dis; 2014 Dec; 29():65-70. PubMed ID: 25449238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
    Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI
    J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.
    Gupta S; Singh S
    BMC Infect Dis; 2010 Mar; 10():53. PubMed ID: 20205948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients.
    Shire NJ; Rouster SD; Stanford SD; Blackard JT; Martin CM; Fichtenbaum CJ; Sherman KE
    J Acquir Immune Defic Syndr; 2007 Mar; 44(3):309-14. PubMed ID: 17159656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and determinants of antibodies to hepatitis C virus and markers for hepatitis B virus infection in patients with HIV infection in Aquitaine. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
    Saillour F; Dabis F; Dupon M; Lacoste D; Trimoulet P; Rispal P; Monlun E; Ragnaud JM; Morlat P; Pellegrin JL; Fleury H; Couzigou P
    BMJ; 1996 Aug; 313(7055):461-4. PubMed ID: 8776313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occult hepatitis B virus infection among chronic hemodialysis patients in Alexandria, Egypt.
    Helaly GF; El Ghazzawi EF; Shawky SM; Farag FM
    J Infect Public Health; 2015; 8(6):562-9. PubMed ID: 26026236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon.
    Gachara G; Magoro T; Mavhandu L; Lum E; Kimbi HK; Ndip RN; Bessong PO
    AIDS Res Ther; 2017 Mar; 14(1):11. PubMed ID: 28270215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occult HBV infection among anti-HBc positive HIV-infected patients in apex referral centre, Eastern India.
    Panigrahi R; Majumder S; Gooptu M; Biswas A; Datta S; Chandra PK; Banerjee A; Chakrabarti S; Bandopadhyay D; De BK; Chakravarty R
    Ann Hepatol; 2012; 11(6):870-5. PubMed ID: 23109450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].
    Zhang RF; Liu L; Zheng YF; Shen YZ; Chen J; Gu SM; Wang JR; Lu HZ
    Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):189-91. PubMed ID: 23967739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy.
    Filippini P; Coppola N; Pisapia R; Scolastico C; Marrocco C; Zaccariello A; Nacca C; Sagnelli C; De Stefano G; Ferraro T; De Stefano C; Sagnelli E
    AIDS; 2006 Jun; 20(9):1253-60. PubMed ID: 16816553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study.
    Hofer M; Joller-Jemelka HI; Grob PJ; Lüthy R; Opravil M
    Eur J Clin Microbiol Infect Dis; 1998 Jan; 17(1):6-13. PubMed ID: 9512175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of hepatitis B virus (HBV) co-infection in HBV serologically-negative South African HIV patients and retrospective evaluation of the clinical course of mono- and co-infection.
    Firnhaber C; Chen CY; Evans D; Maskew M; Schulz D; Reyneke A; Kramvis A
    Int J Infect Dis; 2012 Apr; 16(4):e268-72. PubMed ID: 22305987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hepatitis B virus infection among tuberculosis patients with or without HIV in Goiânia City, Brazil.
    Aires RS; Matos MA; Lopes CL; Teles SA; Kozlowski AG; Silva AM; Filho JA; Lago BV; Mello FC; Martins RM
    J Clin Virol; 2012 Aug; 54(4):327-31. PubMed ID: 22608842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occult hepatitis B virus infection and S gene escape mutants in HIV-infected patients after hepatitis B virus vaccination.
    Aghakhani A; Mohraz M; Aghasadeghi MR; Banifazl M; Vahabpour R; Karami A; Foroughi M; Ramezani A
    Int J STD AIDS; 2016 Oct; 27(11):967-72. PubMed ID: 26384943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients.
    Lo Re V; Frank I; Gross R; Dockter J; Linnen JM; Giachetti C; Tebas P; Stern J; Synnestvedt M; Localio AR; Kostman JR; Strom BL
    J Acquir Immune Defic Syndr; 2007 Mar; 44(3):315-20. PubMed ID: 17159655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of hepatitis B virus infection in Brazilian human immunodeficiency virus infected patients: high prevalence of occult infection and low frequency of lamivudine resistant mutations.
    Sucupira MV; Mello FC; Santos EA; Niel C; Rolla VC; Arabe J; Gomes SA
    Mem Inst Oswaldo Cruz; 2006 Sep; 101(6):655-60. PubMed ID: 17072479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
    Nebbia G; Garcia-Diaz A; Ayliffe U; Smith C; Dervisevic S; Johnson M; Gilson R; Tedder R; Geretti AM
    J Med Virol; 2007 Oct; 79(10):1464-71. PubMed ID: 17705185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.